Clinical Indication

Hyperprolactinaemic disorders


Annual monitoring undertaken in secondary care Primary care should be aware of fibrotic reactions

Date of classification

May 2019


Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.